Global Procalcitonin Test Kit Market Growth 2025-2031

The global Procalcitonin Test Kit market size is predicted to grow from US$ 485 million in 2025 to US$ 719 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.

The procalcitonin test is the measure of the levels of procalcitonin in the blood. The test is used as an indicator of presence or absence of serious bacterial infections, especially sepsis. High levels of procalcitonin in the blood represent the presence of sepsis in the body.

Global key players of Procalcitonin Test Kit include Roche, bioMérieux SA, Beckman Coulter, Thermo Fisher Scientific, Wuhan Easy Diagnosis Biomedicine, etc. The top five players hold a share about 64%. North America is the largest market, and has a share about 40%, followed by Europe and Asia-Pacific with share 30% and 24%, separately. In terms of product type, CLIA is the largest segment, accounting for a share of 59%. In terms of application, Hospitals & Clinic is the largest field with a share about 70 percent.

LP Information, Inc. (LPI) ' newest research report, the “Procalcitonin Test Kit Industry Forecast” looks at past sales and reviews total world Procalcitonin Test Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Procalcitonin Test Kit sales for 2025 through 2031. With Procalcitonin Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Procalcitonin Test Kit industry.

This Insight Report provides a comprehensive analysis of the global Procalcitonin Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Procalcitonin Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Procalcitonin Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Procalcitonin Test Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Procalcitonin Test Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Procalcitonin Test Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

CLIA

ELISA

FIA

Others

Segmentation by Application:

Hospitals & Clinic

Diagnostic Laboratories

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Roche

Thermo Fisher Scientific

bioMérieux SA

Beckman Coulter

Fujirebio Diagnostics

RayBiotech

EKF Diagnostics

Wondfo

Wuhan Easy Diagnosis Biomedicine

Vazyme Biotech

Getein Biotech

Mindray

Key Questions Addressed in this Report

What is the 10-year outlook for the global Procalcitonin Test Kit market?

What factors are driving Procalcitonin Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Procalcitonin Test Kit market opportunities vary by end market size?

How does Procalcitonin Test Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.